These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 3518720)
21. Calorimetric estimate of the enthalpy change for the substrate-promoted conformational transition of aspartate transcarbamoylase from Escherichia coli. Shrake A; Ginsburg A; Schachman HK J Biol Chem; 1981 May; 256(10):5005-15. PubMed ID: 7014568 [No Abstract] [Full Text] [Related]
22. Insights into the mechanisms of catalysis and heterotropic regulation of Escherichia coli aspartate transcarbamoylase based upon a structure of the enzyme complexed with the bisubstrate analogue N-phosphonacetyl-L-aspartate at 2.1 A. Jin L; Stec B; Lipscomb WN; Kantrowitz ER Proteins; 1999 Dec; 37(4):729-42. PubMed ID: 10651286 [TBL] [Abstract][Full Text] [Related]
23. Changes in the hydrogen exchange kinetics of Escherichia coli aspartate transcarbamylase produced by effector binding and subunit association. Lennick M; Allewell NM Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6759-63. PubMed ID: 7031660 [TBL] [Abstract][Full Text] [Related]
24. Comparative physiological disposition of N-(phosphonacetyl)-L-aspartate in several animal species after intravenous and oral administration. Chadwick M; Silveira DM; MacGregor JA; Branfman AR; Liss RH; Yesair DW Cancer Res; 1982 Feb; 42(2):627-32. PubMed ID: 7055806 [TBL] [Abstract][Full Text] [Related]
26. Long-term association of N-(phosphonacetyl)-L-aspartate with bone. Ardalan B; Kensler TW; Jayaram HN; Morrison W; Choie DD; Chadwick M; Liss R; Cooney DA Cancer Res; 1981 Jan; 41(1):150-6. PubMed ID: 7448755 [TBL] [Abstract][Full Text] [Related]
27. 13C isotope effect studies of Escherichia coli aspartate transcarbamylase in the presence of the bisubstrate analog N-(phosphonoacetyl)-L-aspartate. Parmentier LE; O'Leary MH; Schachman HK; Cleland WW Biochemistry; 1992 Jul; 31(28):6598-602. PubMed ID: 1633172 [TBL] [Abstract][Full Text] [Related]
28. Enzymatic assay for the antitumor agent-N-(phosphonacetyl)-L-aspartic acid (PALA). Friedman J; Moore EC; Hall SW; Loo TL Cancer Treat Rep; 1979 Jan; 63(1):85-8. PubMed ID: 421235 [TBL] [Abstract][Full Text] [Related]
30. The 80s loop of the catalytic chain of Escherichia coli aspartate transcarbamoylase is critical for catalysis and homotropic cooperativity. Macol C; Dutta M; Stec B; Tsuruta H; Kantrowitz ER Protein Sci; 1999 Jun; 8(6):1305-13. PubMed ID: 10386880 [TBL] [Abstract][Full Text] [Related]
31. Function of threonine-55 in the carbamoyl phosphate binding site of Escherichia coli aspartate transcarbamoylase. Xu W; Kantrowitz ER Biochemistry; 1989 Dec; 28(26):9937-43. PubMed ID: 2515892 [TBL] [Abstract][Full Text] [Related]
32. The allosteric activator Mg-ATP modifies the quaternary structure of the R-state of Escherichia coli aspartate transcarbamylase without altering the T<-->R equilibrium. Fetler L; Vachette P J Mol Biol; 2001 Jun; 309(3):817-32. PubMed ID: 11397099 [TBL] [Abstract][Full Text] [Related]
33. Site-specific substitutions of the Tyr-165 residue in the catalytic chain of aspartate transcarbamoylase promotes a T-state preference in the holoenzyme. Wales ME; Hoover TA; Wild JR J Biol Chem; 1988 May; 263(13):6109-14. PubMed ID: 3283120 [TBL] [Abstract][Full Text] [Related]
34. Function of serine-171 in domain closure, cooperativity, and catalysis in Escherichia coli aspartate transcarbamoylase. Dembowski NJ; Newton CJ; Kantrowitz ER Biochemistry; 1990 Apr; 29(15):3716-23. PubMed ID: 2111165 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and bioactivity of novel inhibitors of E. coli aspartate transcarbamoylase. Eldo J; Heng S; Kantrowitz ER Bioorg Med Chem Lett; 2007 Apr; 17(7):2086-90. PubMed ID: 17336518 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological disposition of N-(phosphonacetyl)-L-aspartate in humans. Loo TL; Friedman J; Moore EC; Valdivieso M; Marti JR; Stewart D Cancer Res; 1980 Jan; 40(1):86-90. PubMed ID: 7349907 [TBL] [Abstract][Full Text] [Related]
37. Peptide-protein interaction markedly alters the functional properties of the catalytic subunit of aspartate transcarbamoylase. Zhou BB; Schachman HK Protein Sci; 1993 Jan; 2(1):103-12. PubMed ID: 8443583 [TBL] [Abstract][Full Text] [Related]
38. Divergent allosteric patterns verify the regulatory paradigm for aspartate transcarbamylase. Wales ME; Madison LL; Glaser SS; Wild JR J Mol Biol; 1999 Dec; 294(5):1387-400. PubMed ID: 10600393 [TBL] [Abstract][Full Text] [Related]
39. Aspartate transcarbamylase (ATCase) of Escherichia coli: a new crystalline R-state bound to PALA, or to product analogues citrate and phosphate. Huang J; Lipscomb WN Biochemistry; 2004 Jun; 43(21):6415-21. PubMed ID: 15157075 [TBL] [Abstract][Full Text] [Related]
40. A 70-amino acid zinc-binding polypeptide fragment from the regulatory chain of aspartate transcarbamoylase causes marked changes in the kinetic mechanism of the catalytic trimer. Zhou BB; Waldrop GL; Lum L; Schachman HK Protein Sci; 1994 Jun; 3(6):967-74. PubMed ID: 8069226 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]